Bettina E. Mucha

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis

An update on LDL apheresis for nephrotic syndrome

Gout and hyperuricemia

Basement membranes and human disease

Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome

Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic Syndrome

TGF-β: the master regulator of fibrosis

mTOR at the nexus of nutrition, growth, ageing and disease

mTOR Signaling in Growth, Metabolism, and Disease

Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome

Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin

Causes and pathogenesis of focal segmental glomerulosclerosis

The Collagen Family

The Neurology of mTOR

mTOR Signaling in Epilepsy: Insights from Malformations of Cortical Development

A primer on recurrent and de novo glomerulonephritis in renal allografts

AKT/PKB Signaling: Navigating the Network

Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout

Focal Segmental Glomerulosclerosis

Uromodulin Biology and Pathophysiology – An Update

Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach

Transient Receptor Potential Cation Channels in Disease

New Insights into the Pathogenesis and the Therapy of Recurrent Focal Glomerulosclerosis

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy

Mutation of the Wilms’ Tumor 1 Gene Is a Poor Prognostic Factor Associated With Chemotherapy Resistance in Normal Karyotype Acute Myeloid Leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party

Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

Congenital and Infantile Nephrotic Syndrome

Pathobiology of focal segmental glomerulosclerosis

Nephrotic focal segmental glomerulosclerosis in 2004: an update

mTOR: a pharmacologic target for autophagy regulation

Standardization of sample collection, isolation and analysis methods in extracellular vesicle research

Wilms’ Tumor 1 Gene Mutations Independently Predict Poor Outcome in Adults With Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Treatment of focal segmental glomerulosclerosis

Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome

Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome

Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome

Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders

No evidence for genotype/phenotype correlation in NPHS1 and NPHS2 mutations

Mutations of the Uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains

Nephrotic Syndrome in the First Year of Life: Two Thirds of Cases Are Caused by Mutations in 4 Genes (NPHS1, NPHS2, WT1, and LAMB2)

Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly